On this page you will find all of ACB’s publications. To the right are the search categories that will help you navigate around the ACB’s extensive work.
In a totally unexpected move, the newly appointed Tanzania Agricultural Minister, Prof Adolf Mkenda, in mid-January 2021 announced the cancellation of research trials involving genetically modified organisms (GMOs) in the country and the decision to put in place extra biosafety scrutiny of imported genetically modified (GM) seed.
An ACB statement on Human Rights Day, 21 March
Resounding no to Monsanto’s ‘bogus’ GM drought tolerant maize: South Africa’s Minister, Appeal Board and Biosafety Authority Reject Monsanto’s GM seeds
Johannesburg, South Africa, 4 October 2019
On Monday 1st July 2019, Target Malaria announced the release of 6400 genetically modified (GM) sterile male mosquitoes in Bana, a village in Burkina Faso – the first GM insects to be released in Africa. This is Phase I – by Phase III, Target Malaria aims to release gene drive mosquitoes.
In this report, the African Centre for Biodiversity outlines and assesses input subsidy programmes in Mozambique, as part of the larger agriculture policy landscape, and the impact this has had on the agricultural sector, particularly on smallholder farmers.
We, the undersigned civil society organisations in Africa, hereby call upon the Bill and Melinda Gates Foundation and the Target Malaria project to stop the intended release of 10 000 genetically modified (GM) “male sterile” mosquitoes in Burkina Faso, as the release poses unacceptable risks to human beings and the environment.
On the pretext of supporting scientific innovation for malaria eradication, African countries vociferously defended a techno-fix that does not address the wider determinants of malaria – but rather, represents the changing face of colonial medicine and threatens the biodiversity of an entire continent.